CaviWipes™ HP

CaviWipes HP is the newest member of the trusted CaviWipes family providing an effective 1-minute universal contact time from an alcohol-free hydrogen peroxide formulation. The High Performance disinfection protocol offered by CaviWipes HP protects both patients and staff.

Features and Benefits

Simple

Caviwipes HP offers a universal 1-minute contact time against all listed pathogens, offering simplicity and peace of mind for every application. The new green top opens and closes more easily and securely, and dispenses wipes with precision, helping to reduce waste.

Alcohol-Free

CaviWipes HP provides a friendly alternative for those who prefer not to use alcohol-based wipes, and our HP formulation provides better cleaning efficacy than alcohol-based products.

Fast

Our 1-step* and 1-minute universal contact time reduces waiting time for disinfection and increases staff efficiency.

Effective

CaviWipes HP provides effective disinfection against all 66 listed pathogens including MDRO's (Multidrug Resistant Organisms).

_{*Precleaning is required when visibly soiled and/or disinfecting against}_{Candida auris}_{, HIV, HBV and HCV}

New Canister Design

Duck Tail Design - Easy to Open & Close with 1 Hand
Colored Cap - Easier Staff Identification
Strong Hinge -Durable Design
Large Well - Optimal Closure & Wipe, Dry-Out Protection
Optimal Orifice - Easy Wipe Pull, No Tears & No Waste

Kill Claims

Tuberculocidal (TB)

Mycobacterium tuberculosis var: bovis (BCG) (TB)

Viruses (Non-Enveloped)

Human Norovirus
Human Rotavirus
Rhinovirus Type 37
Rhinovirus Type 1A
Human Adenovirus Type 5
Enterovirus Type 71

Viruses (Enveloped)

Herpes simplex virus Type 1 & Type 2
Avian Influenza A virus (H7N9)
Avian Influenza A virus (H5N1)
Influenza A virus (H3N2)
Influenza B virus (H1N1)
Parainfluenza virus Type 3
Human Hepatitis B virus (HBV)
Human Hepatitis C virus (HCV)
Human lmmunodeficiency virus Type 1 (HIV-1)
Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2)
Vaccinia virus
SARS-Associated Coronavirus (SARs-CoV)
Cytomegalovirus (CMV)
Influenza A virus (H1N1) Strains A/4108/2009 and A/04/09
Human Coronavirus
Respiratory Syncytial Virus (RSV)
Measles virus
Human Herpes Virus 3

Pathogenic Fungi

Trichophyton interdigitale
Candida auris
Candida albicans

Multi-Drug-Resistant Pathogenic Fungi

Multidrug-Resistant Candida auris

Bacteria

Pseudomonas aeruginosa
Staphylococcus aureus
Salmonella enterica
Legionella pneumophila
Bordetella pertussis
Enterococcus faecium
Klebsiella aerogenes
Klebsiella pneumoniae
Escherichia coli
Escherichia coli O157:H7
Burkholderia cepacia
Stenotrophomonas maltophilia
Streptococcus pyogenes
Listeria monocytogenes
Shigella dysenteriae
Serratia marcescens
Bordetella bronchiseptica
Proteus vulgaris

Multi-Drug-Resistant Bacteria (MDRO)

Penicillin-Resistant Streptococcus pneumoniae (PRSP)
Vancomycin-Resistant Enterococcus faecalis (VRE)
Methicillin-Resistant Staphylococcus aureus (MRSA)
Hospital-Acquired and Community Acquired Methicillin- Resistant Staphylococcus aureus (HA-MRSA and CA- MRSA)
Vancomycin Intermediate Staphylococcus aureus (VISA)
Vancomycin Resistant Staphylococcus aureus (VRSA)
Linezolid-Resistant Staphylococcus aureus (LRSA)
Carbapenem-Resistant Klebsiella pneumoniae (CRKP/ CRE)
Multidrug-Resistant Acinetobacter baumannii (MRAB) ATCC BAA-1605
NDM-1 Enterobacter cloacae
NDM-1 Klebsiella pneumoniae
NMD-1 Escherichia coli
ESBL Klebsiella pneumoniae
ESBL Escherichia coli
Multidrug-Resistant Klebsiella pneumoniae
Carbapenem-Resistant Escherichia coli